Topics:

Unsafe Blood Still Found in Some Developing Countries

Unsafe Blood Still Found in Some Developing Countries

During the HIV
epidemic in the 1980s, more than half of the hemophiliac patients living in
many countries, including the United States, France, Denmark, and Japan, became
infected with HIV as a result of blood transfusions with contaminated blood or
blood products.[1,2] Since the clotting factor needed to treat hemophiliacs was
manufactured by pooling plasma from thousands of donors, even one HIV-infected
donor could contaminate the entire supply, infecting hundreds.

Several developed countries faced civil litigation that
resulted in the indictment and imprisonment of government officials and
industry leaders for their role in the mismanagement of the blood supply.[3]
Investigations of these individuals revealed that they delayed the
implementation of donor screening policies and/or technologies used to screen
donors and blood supplies for HIV.

Fear of future litigation combined with the development and
implementation of blood donor screening policies and screening tests in the
last 17 years have helped to ensure the safety of the blood supply in developed
countries. Many developing countries, however, have been struggling to adopt
similar safety measures.

Most developing countries cannot afford, nor do they have
the infrastructure required, to implement the effective yet costly methods to
ensure safety employed in developed countries. Some 13 million units, or up to
45% of blood donations in developing countries, are never tested for infections
transmissible by transfusion.[3,4]

In addition, donors in developing countries are often
compensated monetarily, attracting people living in poverty who have a high
risk of carrying HIV, hepatitis C virus, or hepatitis B virus. These people
often donate frequently without regard to the status of their health and the
risk to others.

Thus, 10% of new HIV infections in developing countries are
estimated to result from transfusions using infected blood and blood
products.[4]

India

Pages

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.